Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis.

The results proposed many unknown associations of lipid mediators with cancer, underscoring the need for further studies. In particular, the PS/LysoPS pathway could be a novel therapeutic target, and plasma eicosanoids could be useful biomarkers for cancer.